Skip to main content
Log in

Effect of supplementation of low-molecular-weight chitosan oligosaccharide, GO2KA1, on postprandial blood glucose levels in healthy individuals following bread consumption

  • Research Note
  • Published:
Food Science and Biotechnology Aims and scope Submit manuscript

Abstract

The effect of chitosan oligosaccharide (GO2KA1) administration on postprandial blood glucose levels of subjects with normal blood glucose levels was evaluated following bread consumption. Postprandial blood glucose levels were determined for 2 h after bread ingestion with or without 500 mg of GO2KA1. GO2KA1 significantly lowered the mean, maximum, and minimum levels of postprandial blood glucose at 30 min after the meal. Postprandial blood glucose levels were decreased by about 25% (from 155.11±13.06 to 138.50±13.59, p<0.01) at 30 min when compared to control. Furthermore, we observed that the area under the concentration-time curve (AUCt) was decreased by about 6% (from 255.46±15.43 to 240.15±14.22, p<0.05) and the peak concentration of blood glucose (C max) was decreased by about 11% (from 157.94±10.90 to 140.61±12.52, p<0.01) when compared to control. However, postprandial the time to reach C max (Tmax) levels were the same as those found in control. Our findings suggest that GO2KA1 limits the increase in postprandial blood glucose levels following bread consumption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Supplement 1): S64–S71 (2012)

    Article  Google Scholar 

  2. Centers for Disease Control and Prevention. Diabetes Report Card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services (2015)

    Google Scholar 

  3. James PB, Theodore JT, Edward WG, Lawrence EB, David FW. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metrics 8: 29 (2010)

    Article  Google Scholar 

  4. Adam GT, Christian H, Wolfgang R, Eric JB, Mika K. Prediabetes: A high-risk state for diabetes development. Lancet 379: 2279–2290 (2012)

    Article  Google Scholar 

  5. David MN, Rury RH, John BB, Robert S, Mayer BD, Bernard Z, Ele F. Medical management of hyperglycemia in Type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 32: 193–203 (2009)

    Article  Google Scholar 

  6. Derosa G, Maffioli P. a-Glucosidase inhibitors and their use in clinical practice. Arch. Med. Sci. 8: 899–906 (2012)

    Article  CAS  Google Scholar 

  7. No HK, Park NY, Lee SH, Samuel PM. Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int. J. Food Microbiol. 74: 65–72 (2002)

    Article  CAS  Google Scholar 

  8. Koji H, Mikio I. Action of low molecular weight chitosan in genetically obese diabetic KK-Ay Mice. Biol. Pharm. Bull. 25: 188–192 (2002)

    Article  Google Scholar 

  9. Lee H-W, Park Y-S, Choi J-W, Yi S-Y, Shin W-S. Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats. Biol. Pharm. Bull. 26: 1100–1103 (2003)

    Article  CAS  Google Scholar 

  10. Cynthia MG, Jessa M, Robert HJ, John W, Daniel DG. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J. Nutr. 130: 2753–2759 (2000)

    Google Scholar 

  11. Qin C, Du Y, Xiao L, Li Z, Gao X. Enzymic preparation of water-soluble chitosan and their antitumor activity. Int. J. Biol. Macromol. 31: 111–117 (2002)

    Article  CAS  Google Scholar 

  12. Qi L, Xu Z. In vivo antitumor activity of chitosan nanoparticles. Bioorg. Med. Chem. Lett. 16: 4243–4245 (2006)

    Article  CAS  Google Scholar 

  13. Yen MT, Yang JH, Mau JL. Antioxidant properties of chitosan from crab shells. Carbohyd. Polym. 74: 840–844 (2008)

    Article  CAS  Google Scholar 

  14. Tao S, Dongxiang Z, Junlin X, Fang M. Preparation of chitosan oligomers and their antioxidant activity. Eur. Food Res. Technol. 225: 451–456 (2007)

    Article  Google Scholar 

  15. Jo SH, Ha KS, Moon KS, Kim JG, Oh CG, Kim YC, Apostolidis E, Kwon YI. Molecular weight dependent glucose lowering effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model. Int. J. Mol. Sci. 14: 14214–14224 (2013)

    Article  Google Scholar 

  16. Jo SH, Ha KS, Lee JW, Kim YC, Apostolidis E, Kwon YI. The reduction effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose levels in healthy individuals. Food Sci. Biotechnol. 23: 971–973 (2014)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young-In Kwon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, YR., Choi, HY., Lee, JY. et al. Effect of supplementation of low-molecular-weight chitosan oligosaccharide, GO2KA1, on postprandial blood glucose levels in healthy individuals following bread consumption. Food Sci Biotechnol 25, 911–914 (2016). https://doi.org/10.1007/s10068-016-0149-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10068-016-0149-9

Keywords

Navigation